Metastatic Prostate Cancer: Complications and Treatment
- 31 July 2003
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 51 (8) , 1136-1142
- https://doi.org/10.1046/j.1532-5415.2003.51367.x
Abstract
Despite highly successful treatments for localized prostate cancer, approximately 35% to 40% of men will eventually experience a detectable rise in serum prostate specific antigen. A portion of these...Keywords
This publication has 39 references indexed in Scilit:
- Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and PharmacokineticsJournal of Clinical Oncology, 2002
- SAFETY AND EFFICACY OF EXISULIND FOR TREATMENT OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYJournal of Urology, 2001
- What’s new in urologyJournal of the American College of Surgeons, 2001
- Pain Management in Older Adults: Prevention and TreatmentJournal of the American Geriatrics Society, 2001
- THE USE OF BISPHOSPHONATE FOR THE PALLIATIVE TREATMENT OF PAINFUL BONE METASTASIS DUE TO HORMONE REFRACTORY PROSTATE CANCERJournal of Urology, 2001
- INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINEJournal of Urology, 2000
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCERJournal of Urology, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999